PharmAthene Submits Response to DHHS Request for Proposals for SparVax(TM) - A Recombinant Protective Antigen Vaccine (PR Newswire, 2008)
Keywords: Agreements; Anthrax; Antigens; Biological & chemical terrorism; Biological & chemical weapons; Human subjects; Monoclonal antibodies; Pharmaceutical industry; Product development; Vaccines; ANNAPOLIS, Md